Maternal vitamin D supplementation during pregnancy and lactation to promote infant growth in Dhaka, Bangladesh (MDIG trial): study protocol for a randomized controlled trial
Authors:
- Daniel E. RothDRDaniel E. Roth
- Alison D. GernandAGAlison D. Gernand
- Shaun K. MorrisSMShaun K. Morris
- Brendon PezzackBPBrendon Pezzack
- M. Munirul IslamMIM. Munirul Islam
- Michelle C. DimitrisMDMichelle C. Dimitris
- Shaila S. ShantaSSShaila S. Shanta
- Stanley H. ZlotkinSZStanley H. Zlotkin
- Andrew R. WillanAWAndrew R. Willan
- Tahmeed AhmedTATahmeed Ahmed
- Prakesh S. ShahPSPrakesh S. Shah
- Kellie E. MurphyKMKellie E. Murphy
Open Access
- 14 July 2015
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 16 (1) , 300
Abstract
Vitamin D regulates bone mineral metabolism and skeletal development. Some observational studies have suggested that prenatal vitamin D deficiency increases the risk of adverse pregnancy and/or birth outcomes; however, there is scant evidence from controlled trials, leading the World Health Organization to advise against routine vitamin D supplementation in pregnancy. Importantly, little is known about the effect of maternal vitamin D status on infant linear growth in communities in South Asia where stunting is highly prevalent and maternal-infant vitamin D status is commonly suboptimal. The Maternal Vitamin D for Infant Growth study is a randomized, placebo-controlled, dose-ranging trial of maternal vitamin D supplementation during pregnancy and lactation in Dhaka, Bangladesh. The primary aims are to estimate (1) the effect of maternal prenatal oral vitamin D3 supplementation (4200 IU/wk, 16,800 IU/wk, or 28,000 IU/wk, administered as weekly doses) versus placebo on infant length at 1 year of age and (2) the effect of maternal postpartum oral vitamin D3 supplementation (28,000 IU/wk) versus placebo on length at 1 year of age among infants born to women who received vitamin D 28,000 IU/wk during pregnancy. Generally healthy pregnant women (n = 1300) in the second trimester (17–24 weeks of gestation) are randomized to one of five parallel arms: placebo 4200 IU/wk, 16,800 IU/wk, or 28,000 IU/wk in the prenatal period and placebo in the postpartum period or 28,000 IU/wk in the prenatal period and 28,000 IU/wk in the postpartum period. Household- and clinic-based follow-up of mother-infant pairs is conducted weekly by trained personnel until 26 weeks postpartum and every 3 months thereafter. The primary trial outcome measure is length for age z-score at 1 year of age. Anthropometric measurements, clinical information, and biological specimens collected at scheduled intervals will enable the assessment of a range of maternal, perinatal, and infant outcomes. The role of vitamin D in maternal and infant health remains unresolved. This trial is expected to contribute unique insights into the effects of improving maternal-infant vitamin D status in a low-income setting where stunting and adverse perinatal outcomes represent significant public health burdens. ClinicalTrials.gov identifier: NCT01924013 . Registered on 13 August 2013Keywords
This publication has 65 references indexed in Scilit:
- Randomized placebo-controlled trial of high-dose prenatal third-trimester vitamin D3 supplementation in Bangladesh: the AViDD trialNutrition Journal, 2013
- Pharmacokinetics of High-Dose Weekly Oral Vitamin D3 Supplementation during the Third Trimester of Pregnancy in Dhaka, BangladeshNutrients, 2013
- Trends in mild, moderate, and severe stunting and underweight, and progress towards MDG 1 in 141 developing countries: a systematic analysis of population representative dataThe Lancet, 2012
- Vitamin D During Pregnancy and Maternal, Neonatal and Infant Health Outcomes: A Systematic Review and Meta‐analysisPaediatric and Perinatal Epidemiology, 2012
- MAVIDOS Maternal Vitamin D Osteoporosis Study: study protocol for a randomized controlled trial. The MAVIDOS Study GroupTrials, 2012
- Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectivenessJournal of Bone and Mineral Research, 2011
- A novel approach identifies new differentially methylated regions (DMRs) associated with imprinted genesGenome Research, 2011
- Maternal plasma 25‐hydroxyvitamin D concentration and birthweight, growth and bone mineral accretion of Gambian infantsActa Paediatrica, 2009
- Maternal and child undernutrition: consequences for adult health and human capitalThe Lancet, 2008
- Maternal and child undernutrition: global and regional exposures and health consequencesThe Lancet, 2008